This report provides exclusive insights into the COVID-19 impact on the Continuous Blood Glucose Monitoring Systems Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Continuous Blood Glucose Monitoring Systems Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Continuous Blood Glucose Monitoring Systems Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by
Infinium Global Research on continuous blood glucose monitoring systems market
provides a depth analysis of segments and sub-segments in the global as well
as regional continuous blood glucose monitoring systems market. The study also
highlights the impact of drivers, restraints, and macro indicators on the
global and regional continuous blood glucose monitoring systems market over the
short term as well as long term. The report is a comprehensive presentation of
trends, forecast, and dollar values of the global continuous blood glucose
monitoring systems market. According to the report, the global continuous blood
glucose monitoring systems market is projected to grow at a CAGR of 12.9% over
the forecast period of 2019-2025.
During the last four decades, there have been continuous
advances in the field of glucose monitoring, which have led to the development
of highly evolved blood glucose meters, including non-invasive glucose
monitoring (NGM) devices and continuous blood glucose monitoring systems (CGM).
Glucose monitoring is an integral part of diabetes management and the
maintenance of physiological blood glucose concentration is the only way for a
diabetic to avoid life-threatening diabetic complications. CGM systems have led
to tremendous improvements in diabetic management, as shown by the significant
lowering of glycated hemoglobin (HbA1c) in adults with type I diabetes. Most of
the CGMS has been minimally-invasive, although the more recent ones are based
on NGM techniques
Diabetes disease is growing across the globe at an
extraordinary pace and has become a serious health issue during the last two
decades. It is a major cause of mortality in the age group of 20–79 years.
Based on its rapidly increasing incidence, it has been declared a global
epidemic by the World Health Organization (WHO). According to the International
Diabetes Federation (IDF), the number of diabetic patients reached 415 million
in 2015 globally and is expected to reach around 642 million by 2040. According
to the IDF, global healthcare expenditures to treat diabetes and its
complications were USD 673 billion in 2015, representing 12% of total global
healthcare expenditures and is expected to exceed USD 802 billion by 2040. Rise
in the base of geriatric population, increasing incidence rates of diabetes
worldwide, benefits of CBGM devices over blood glucometers such as reports
generation and access for historic blood glucose data to analyze the trend,
growing awareness among the population, increasing preference for non-invasive
methods and approval of artificial pancreas from FDI is expected to drive the
market at a significant growth rate in the coming years. However, stringent
regulatory approvals and high costs associated with these devices are some of
the restraining factors, which could hinder the market.
Among the geographies, North America holds the maximum
market share of continuous blood glucose monitoring systems (CGM) market
followed by Europe. The rapidly growing prevalence of diabetes and growing
awareness about the prevention of diabetes is the key factors that drive the
growth of North America continuous glucose monitoring system market.
Additionally, favorable government and developed healthcare infrastructures are
majorly contributing to the growth of this market in the North America region.
Moreover, Asia Pacific is the fastest-growing region in the glucose monitoring
systems (CGM) market owing to the growing prevalence of diabetes, rapidly
changing lifestyles, and growing geriatric population.
The report on global continuous
blood glucose monitoring systems market covers segments such as component. On
the basis of component, the sub-markets include CGM monitor, CGM transmitter,
and glucose sensor.
The report provides profiles of
the companies in the market such as Dexcom, Inc., Medtronic plc, Abbott Laboratories, Integrity
Applications Incorporated, Novo Nordisk A/S, ORSENSE LTD, Bayer AG, Johnson
& Johnson Services, Inc., Senseonics Holdings,
Inc., and Other Companies.
The report provides deep insights
into the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of continuous blood glucose monitoring systems market. Moreover, the
study highlights current market trends and provides forecast from 2019-2025. We
also have highlighted future trends in the market that will affect the demand
during the forecast period. Moreover, the competitive analysis given in each
regional market brings an insight into the market share of the leading players.